title: Gemicitabine-induced radiation recall phenomenon in 2 distinctive sites on the same patient.
abstract: Radiation recall phenomenon is an acute inflammatory reaction that develops in previously irradiated areas after administration of inciting agents systemically. The most common agents are anticancer drugs. Gemcitabine, a fluorine-substituted deoxycytidine analog, is widely used as a chemotherapy medication. Its antitumor effect results from the blockade of DNA synthesis and DNA repair. It has been used in advanced pancreatic, non-small-cell lung, bladder, and ovarian cancers; soft-tissue sarcoma; and non-Hodgkin lymphoma. It has occasionally been reported to cause radiation recall phenomenon. The time between radiation and recall may range from weeks to almost a year.
authors: Department of Internal Medicine, Albany Medical Center, Albany, NY USA Email: Zhangl1@mail.amc.edu.
authors: Lulu
authors: L
authors: Zhang
authors: Raina
authors: R
authors: Patel
authors: Syed
authors: S
authors: Mehdi